Merck & Co. (NYSE:MRK)Signs $356 Million Deal for Supply of Its COVID-19 Treatment in the US
Merck & Co. (NYSE:MRK) has signed a $356 million supply deal with the US government for the supply of 60,000
Read more
COVID-19 treatment
DRP Journal
Discover Research Profit